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Abstract
The Liangshan prefecture in Sichuan province is an area in China
severely affected by the HIV epidemic, with intravenous drug
use (IDU) as the main risk factor. No reports on HIV subtypes
prevalent in IDUs in Liangshan prefecture could be found. In this
study, we have characterized the genotypes of HIV-1 in the IDU
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population in Liangshan prefecture and further determined the
phylogenetic relationship of the CRF07_BC strains to HIV-1
sequences from the other regions of China, including Xinjiang
and Yunnan provinces, to explore the pattern and possible
diffusion pathway of HIV-1 in these regions. HIV-1-seropositive
drug-naive IDUs identified in Liangshan prefecture, Sichuan
province were enrolled in 2009. Full-length gag and pol genes
were amplified by reverse transcription and nested PCR and
then sequenced. All of the sequences were subtyped.
Phylogenetic trees were constructed using the neighbor-joining
and maximum likelihood methods. Divergence times were
estimated using a Bayesian molecular clock approach.
CRF07_BC was found to be the predominant strain in IDUs in
Liangshan prefecture (95.5%). The CRF07_BC strains from
Liangshan prefecture were found to be intermixed with those
from Yunnan province in phylogenetic trees. The CRF07_BC
sequences from Xinjiang province can be grouped into several
clusters, suggesting that the expansion of the CRF07_BC
epidemic in Xinjiang province was the result of a local epidemic
driven by multiple independent introductions in the late 1990s.
Only low-level drug-resistant viruses were found in the IDU
population. CRF07_BC strains from Liangshan prefecture were
more similar to those from Yunnan province than those from
Xinjiang province. This finding will contribute to our
understanding of the distribution, the evolution, and the potential
source of CRF07_BC founder strains, and will also provide
useful information for the development of strategies to prevent
transmission.

Introduction
HIV DISPLAYS EXTRAORDINARY genetic diversity due to errors in reverse
transcription during viral replication and its ability to generate recombinant
strains in infected cells.1–3 Four major groups of HIV-1, M, N, O, and P,
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have been identified. Among them HIV-1 group M (HIV-M, major) is
responsible for the current pandemic; it can be further classified into nine
subtypes and more than 60 circulating recombinant forms (CRFs).4 HIV-1
infections caused by CRFs have increased substantially in the past decade,
and are now responsible for more than 20% of HIV-1 infections
worldwide.5–7 CRF07_BC is one of the most prevalent CRFs in China.8–13
This CRF was first identified in the intravenous drug use (IDU) population
in Xinjiang province in 1997,8,9 but recent studies have shown that
CRF07_BC has been introduced into the men who have sex with men
(MSM) population, suggesting that it has spread to different regions of
China and across different high-risk groups.14,15
Several studies were carried out in China to analyze the transmission and
spread of the CRF07_BC strain, resulting in two hypotheses to address the
temporal and spatial dynamic of the spread of CRF07_BC in the country.
One hypothesis suggests that CRF07_BC originated in Yunnan and spread to
Sichuan, Gansu, and finally to Xinjiang province along the drug trade
route.16 The other hypothesis highlighted the important role of Xinjiang
province in the CRF07_BC epidemic and proposed that the transmission of
both HIV and hepatitis C virus (HCV) from Xinjiang to Yunnan
accompanied drug traffic routes.17 However, both hypotheses were
developed based on a small number of CRF07_BC sequences.
Recently, another study analyzing more sequences proposed that CRF07_BC
was first introduced into Yunnan province and then into Xinjiang province
along drug-transporting routes, and then spread into other provinces of
China from Xinjiang.18 However, a limitation of this study is that very few
sequences were obtained and analyzed from Sichuan province, which is
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located along the drug-transporting route between Yunnan and Xinjiang
province. Analyzing a larger number of CRF07_BC sequences from Sichuan
province would be needed to determine whether this diffusion pathway
indeed took place.
Liangshan prefecture is an area located in Sichuan province with IDU
known to be the main HIV diffusion pathway. It is located along the drug
trafficking routes from the “Golden Triangle” to northwest and central
China,19–22 therefore it is not surprising to find a high prevalence of HIV-1
infection in Liangshan prefecture due to IDU.23–25 The first HIV case in
Liangshan prefecture was reported in 1995. In recent years, the incidence of
HIV infection has increased significantly. According to a report from the
Liangshan prefecture HIV epidemiological survey of the Chinese National
Center for AIDS/STD Control and Prevention, of the total number of
HIV/AIDS cases in Liangshan prefecture 81.5% were infected in the past 5
years. By the end of June 2009, the cumulative number of individuals
infected with HIV in Liangshan prefecture was reported to be 15,700,
including 528 AIDS cases and 700 deaths. Injection drug use was the main
infection risk factor (unpublished data, China-MSD HIV/AIDS Partnership
annual summary meeting, Liangshan prefecture).
Given the recent changing profile of the HIV epidemic with the shift of
high-risk behaviors from IDU to sexual contact, it will be important to
determine the recent sources of transmission within the region in IDUs, and
also to illustrate whether the transmission is occurring within the population
or from sources outside by other infected populations. More importantly,
there is a need to determine whether the infected IDUs in the region could
also serve as a source of transmission to other regions of China. Several
studies have reported on the HIV epidemic in IDUs in Liangshan prefecture;
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however, most of them focused on behavioral studies and there is so far no
data on genetic characterizations of the transmitted HIV-1.
Genetic and temporal dynamic analyses have been important tools with
which to study genetic diversity and phylodynamics. This has been used to
reconstruct the history of the HIV epidemic and has provided important
information to aid in the development of strategies for the prevention of
HIV-1 transmission. Genetic analysis in the determination of the HIV
genotype is a key to identifying the distribution of HIV-1 infection in the
population and can potentially link this to the source of transmission.
Therefore in an attempt to determine the potential source of transmission in
the region, in this study we have characterized the HIV-1 strains in IDUs in
Liangshan prefecture based on the full-length HIV-1 gag to determine the
distribution of HIV-1 subtype infections in our study population and its
relationship to HIV viral genotypes from other regions of China. We have
also determined the viral pol gene sequence to investigate the existence of
drug-resistant variants in the population.

Materials and Methods
Study subjects and specimens
HIV-positive drug-naive individuals were randomly recruited from the local
HIV/AIDS sentinel surveillance sites in Liangshan prefecture with informed
consents. The CD4+ T cells counts were determined using flow cytometry
and reagents provided by Becton Dickinson Biosciences (San Jose, CA) with
fresh whole blood specimens before the plasma was separated; the plasma
was then stored at −80°C; until use. The Ethical Review Board, Science and
Technology Supervisory Committee at the Beijing Institute of Microbiology
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and Epidemiology approved the study.

HIV-1 RNA extraction, amplification, and sequencing
Viral RNA was extracted from 500 μl of HIV-1-positive plasma specimens
using a high pure viral RNA kit (Roche, Basel, Switzerland). Viral fulllength gag and pol genes were amplified separately after reverse
transcription and nested polymerase chain reaction (PCR) as described
previously.26 Positive PCR products were sequenced by the Beijing Liuhe
Huada gene technology company (BGI, Beijing, China) with a variety of
internal specific primers (available on request) after purification.

Genotyping and phylogenetic analysis of HIV-1 sequences
The sequenced fragments were edited and assembled as described.27 To
check for potential contamination, the sequences obtained were compared to
all known sequences in the HIV sequence database and all previous
sequences identified in our laboratory using the Basic Local Alignment
Search Tool (BLAST) search (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Sequences with 100% identity were considered to be contaminated. The HIV
genotype was determined using the national center for biotechnology
information viral genotyping tool
(www.ncbi.nih.gov/projects/genotyping/formpage.cgi).
This was carried out by combining both gene fragments from the same
isolate and then further confirmed by phylogenetic analysis with reference
sequences using the neighbor-joining method in MEGA 5.028 and the
maximum likelihood method in PhyML3.0.29 For maximum likelihood
analysis, the nucleotide substitution model was first selected with
jModelTest software,29,30 SPR was used for tree searching, and the
6

reliability of topologies was estimated by performing bootstrap analysis
with 104 replicates. The possible intersubtype mosaicism was screened with
the online Recombination Identification Program (version 3.0; http://hivweb.lanl.gov) and further confirmed by the online software jpHMM-HIV
(http://jphmm.gobics.de/).

Bayesian Markov chain Monte Carlo (MCMC) evolutionary analysis
MCMC analysis was fulfilled step by step as described.31 First, all of
recombinant sequences detected by using RDP software were removed.
Second, the dataset was balanced to maximize the “clock-likeness” of the
data. To do this, a similar number of sequences from each time point and as
many time points as possible were selected. Samples from the most
overrepresented time points (2009 year) were randomly removed. Third,
Path-O-Gen software was used to test the existence of an actual molecular
clock signal by observing the regression between root-to-tip divergence and
sampling data. Fourth, the nucleotide substitution model was selected by
using jModelTest software. Fifth, the best demographic model was selected
using Bayes Factors criteria. Sixth, phylogenies were inferred using BEAST
v.1.7.5 with models selected above and other default parameters.
Simulations were run until convergence (i.e., an effective sample size
greater than 200 for all parameters). The first 10% of the output was used as
a burn-in. The results were summarized using Tracer v.1.5. Maximum clade
credibility (MCC) trees were summarized using TreeAnnotator v.1.6.2, and
the final trees were edited using Figtree v.1.3.1.32

Drug resistance analysis
Drug resistance mutations (DRMs) profiles and antiretroviral susceptibility
were determined using the World Health Organization 2009 list of
7

mutations for surveillance of TDR as implemented in the Calibrated
Population Resistance tool (v.5.0 beta)33,34 (http://hivdb.stanford.edu).

Results
Characteristics of participants for the study
A total of 502 participants residing in Liangshan prefecture (Fig. 1) who
were confirmed as having HIV in 2007 and 2008 were enrolled in the study
in 2009 (Table 1). Most (97.4%) were infected through intravenous drug use.
The average age of the participants was 31.1 years old (ranging from 3 to 62
years). The Yi ethnic minority is the main ethnicity in our study population.
The CD4 T cell counts varied widely, ranging from 22 to 1,446 cells/μl.
Among the 502 participants, 489 subjects were infected by HIV through
IDU and were subjected to further detailed analysis.
View larger version

FIG. 1. Geographic location of Liangshan prefecture in China and
area information of reference sequences. Map of China highlighting
Liangshan prefecture, Sichuan province. Provinces containing
reference sequences for CRF07_BC phylogenetic analysis are labeled in color
according to that used in the maximum likelihood (ML) tree and maximum clade
credibility (MCC) tree. Color images available online at www.liebertpub.com/aid

See full table

TABLE 1. BACKGROUND CHARACTERISTICS OF PARTICIPANTS
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Prevalence of HIV-1 subtypes
From 489 participants, 392 full-length gag genes (80.2%) and 284 fulllength pol genes (58.1%) were successfully obtained. Among them, both gag
and pol genes were identified from 280 samples (57.3%). Based on their
sequences, the subtype variants from 401 participants (82.0%) were
determined. The other samples failed to amplify either gene fragment
possibly due to low viral load and/or sequence variations at the primer
binding sites. A Basic Local Alignment Search Tool (BLAST) search
showed no evidence of sample contamination. Analysis of sequences
showed that all the gene structures were normal with the proper open
reading frames.
According to the National Center for Biotechnology Information (NCBI)
viral genotyping tool, 383 CRF07_BC (95.5%) strains, 12 CRF08_BC (3.0%)
strains, 3 CRF01_AE (0.7%) strains, and 3 subtype C (0.7%) strains were
identified from 401 positive samples. The subtype of each strain was further
confirmed by phylogenetic analysis using the reference sequences
representing subtypes A–D, F–H, J, K, CRF01_AE, CRF07_BC, and
CRF08_BC (www.hiv.lanl.gov) (Fig. 2). Our results thus suggest that
CRF07_BC is the dominant strain that is circulating in Liangshan
prefecture.

9

View larger version

FIG. 2. Phylogenetic tree analysis. Neighbor-joining trees were
created with the full length gag (a) and pol (b) genes of HIV-1
sequences from the intravenous drug use (IDU) population in
Liangshan prefecture and a selection of reference sequences of subtype A–D, F–H, J,
K, CRF01_AE, CRF07_BC, and CRF08_BC (black dots, http://hiv-web.lanl. gov/).
The lengths of the gag and pol genes of HIV-1 sequences obtained in the study were
1,503 and 3,056 base pairs using HXB2 as the genomic calibrator. Each reference
sequence is labeled with the HIV-1 subtype, followed by the sequence name. The
bootstrap values supporting the branch (more than 70%) are indicated at the
corresponding nodes of the tree. The scale bars representing genetic distances are
listed below.

Phylogenetic relationship among CRF07_BC strains prevalent in
Liangshan prefecture and in other areas in China
Investigation of the geographic relationship between Liangshan CRF07_BC
strains and those from other areas will be useful in determining the temporal
dynamics of the CRF07_BC strain. For this purpose, the gag and pol gene
fragments derived from same variant were first assembled for phylogenetic
analysis to obtain the strongest phylogenetic signal. All CRF07_BC
sequences covering the full-length gag and pol regions were downloaded
from the HIV sequence database, including six from Xinjiang, one from
Taiwan, five from Sichuan, three from Liaoning, one from Hebei, one from
Guangxi, and five with the areas of origin uncertain. Considering that fewer
sequences were obtained from other areas as compared to Liangshan, 86
CRF07_BC sequences (12 from Beijing, 19 from Guangxi, 1 from Henan,
and 54 from Yunnan) obtained from another cohort in our laboratory were
also added into the dataset. All sequences were aligned together along with
four subtype C references as the outgroup. A maximum likelihood (ML) tree
was constructed using the GTR+I+G model of nucleotide substitution.
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In the phylogenetic tree, two clusters containing 10 or more sequences were
identified; one is composed of sequences from Guangxi, Hebei, Yunnan, and
Liaoning provinces (Cluster I) and the other is composed of sequences from
Guangxi province (Cluster II), suggesting that HIV from specific
populations in different regions is clustered (Cluster I) while others are
unique for that region (Cluster II). Most sequences from Liangshan
prefecture were distributed evenly in the phylogenetic tree and intermixed
with those from Yunnan province, and only several small clusters
containing three to seven sequences were identified.
Xinjiang province is considered a key area for the phylogenetic study of the
CRF07_BC strain and has been proposed to be the source of the strain.
However, few sequences coving full-length gag and pol segments can be
found. To include CRF07_BC strains from Xinjiang province into the
phylogenetic analysis, a new dataset containing short CRF07_BC sequences
was constructed. For this purpose, all CRF07_BC sequences with geographic
information were downloaded from the HIV sequence database
(www.hiv.lanl.gov/content/index).
Sequences from different areas were separated and manually selected in
order to maximize the length and the number of segments analyzed. Based
on this criteria, 8 sequences from Beijing, 20 from Guangxi, 7 from Hebei
and Henan, 8 from Yunnan, 8 from Liaoning, 1 from Taiwan, and 290 from
Xinjiang spanning 1,473 bp of the gag gene (from 817 to 2,289 according to
the HXB2 calculator) were selected. The distribution of Liangshan
sequences in the ML tree was similar as shown in trees constructed with
full-length gag–pol sequences (Fig. 3). Several large clusters were identified
containing sequences isolated in Xinjiang province, suggesting that the
CRF07_BC epidemic in Xinjiang province might be a result of multiple
11

introductions from Sichuan or Yunnan province.
View larger version

FIG. 3. Evolutionary relationship between Liangshan HIV-1
CRF07_BC sequences from the IDU population and those from
other areas in China depicted on a maximum likelihood tree of the
full-length gag–pol gene (A) and partial gag gene (B). (A) Full-length
gag–pol sequences representing CRF07_BC from several areas
were identified in the laboratory or obtained from the database (http://hiv-web.lanl.
gov/) and used for comparison with the sequences generated in this study. Each
reference sequence is labeled using the same color used in Fig. 1. The branch
support values (more than 70%) are indicated at the corresponding nodes of the tree.
The subtree containing clusters is illustrated at the right of the original tree. (B) The ML
tree based on partial CRF07_BC gag sequences representing CRF07_BC from
several areas is constructed to illustrate the evolutionary relationship between strains
from Liangshan prefecture and Xinjiang province. The subtree containing clusters is
illustrated accordingly. Color images available online at www.liebertpub.com/aid

Estimated timeline of the expansion of CRF07_BC in China
The final dataset for MCMC analysis was set up using 151 CRF07_BC
sequences selected from the phylogenetic analysis dataset containing the
1,473-bp length gag gene (Fig. 4). The general time reversible (GTR)
nucleotide substitution model, strict clock model, and Bayesian skyline
demographic model were selected for MCMC analysis. In the MCC tree,
nine clusters were observed. Among of them, eight clusters (Clusters 2–9)
were composed of sequences from Xinjiang and the other one (Cluster 1)
was composed of sequences from four other provinces or cities (Beijing,
Hebei, Liaoning, and Guangxi). The tMRCAs of CRF07_BC were similar to
those in previous studies.16 All of the Xinjiang clusters were introduced into
the area at the end of 1990s (between 1996 and 1999), which is similar to
the time that CRF07_BC was introduced into Taiwan.16 Cluster V was
founded in the early 2000s, which is later than the other clusters.
12

View larger version

FIG. 4. Maximum clade credibility trees of the HIV-1
CRF07_BC sequences from China based on the partial gag
gene. All of the sequences are labeled using the same colors
used in Fig. 1. The dates of MRCA and posterior probability are labeled beside each
node. Color images available online at www.liebertpub.com/aid

Drug-resistant analysis
The 284 full-length pol genes obtained in the study were screened on line
for the presence of transmitted drug-resistant mutations (see Materials and
Methods). Because most of the drugs used for AIDS therapy in China are
still limited to reverse transcriptase inhibitors (RTIs) and protease inhibitors
(PIs), the RTI and protease transmitted drug-resistant mutations were
analyzed separately. So far only 4 of the 284 strains under investigation
showed major mutations (D67N, D103N, G190A, and T215I separately),
which is known to be associated with drug resistance to RTIs (Table 2). The
overall prevalence of mutations conferring resistance to RTIs was 1.4%.
See full table

TABLE 2. PRIMARY DRUG-RESISTANT MUTATIONS
ASSOCIATED WITH PROTEASE AND REVERSE TRANSCRIPTASE
GENES AMONG TREATMENT NAÏVE PARTICIPANTS

To investigate protease-transmitted drug-resistant mutations, the amino acid
sequence of each strain was compared to the subtype B consensus amino
acid sequence using the published HIV drug resistance software tools from
the International Aids Society USA (IAS-USA) and only a single major
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mutation (M46L) was seen in one sequence from our collected viral
sequences. The overall prevalence of mutations conferring resistance to PIs
was 0.35%.

Discussion
Sichuan province is one of the epicenters of the HIV/STI epidemic in China.
By 2008, there were 19,375 HIV infections reported in Sichuan province,
which ranked sixth among all provinces/autonomous regions in China.35
IDU was the primary diffusion pathway of HIV in Sichuan (75.6%).36
Liangshan is the largest autonomous prefecture of the ethnic minority, the
Yi nationality in China, with 46.5% of the population belonging to the Yi
ethnic group. Among this group, cultural traditions lead to more frequent
casual sexual behavior. Thus, heterosexual transmission from persons
infected through IDU may become a major HIV transmission risk for the
general population in the Liangshan prefecture. We believe this is the first
large-scale molecular epidemiological study to analyze the spread of HIV-1
in IDUs in Liangshan prefecture, Sichuan province. CRF07_BC was shown
to be the dominant strain. The detailed sequence information of CRF07_BC
strains prevalent in Liangshan prefecture, Sichuan province will provide
clues for the analysis of CRF07_BC temporal dynamics in China.
IDU is one of the major risk factors for HIV infection, which has led to
approximately 5–10% of HIV infections worldwide.37 In China, the number
of drug users has consistently increased in the past decade. In 1997, the
number of registered drug users was 70,000. In 2005, the number has
increased to 1.16 million. However, the actual number could be as high as
3.5 million. Furthermore, the prevalence of HIV infection among drug users
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had also increased from 35% in 1995 to 49% in 2004. Among the 780,000
people living with HIV/AIDS in China, 16.9% were infected through IDU
(2011).38 Although the ratio is currently not as high as for sexually
transmitted individuals, most of the IDUs in China also engaged in high-risk
sexual behaviors that led to a rapid spread of HIV between IDUs and other
populations.39 Between 34% and 72% of the female IDUs in China were
reported to have commercial sex partners and 31.8% have nonregular sex
partners; both groups had inconsistent condom usage.40–42
Several studies reported that many IDUs were also MSM in China43,44 and
to obtain drugs, some IDUs were also likely to trade sex for money,45 which
facilitated HIV-1 transmission from IDUs to other populations via
heterosexual or MSM transmission (from male IDUs to MSM).46 A number
of international reports have pointed out that the overlap between injecting
drug use behaviors and sexual risk behaviors is the main driving force of the
HIV epidemic in China.47,48 Thus, surveillance of the HIV epidemic in
IDUs would be helpful for predicting the spread of the HIV epidemic in the
general population.
There is still controversy about the hypothesis concerning the temporal
dynamics of CRF07_BC in Asia. In this study, CRF07_BC strains from
Liangshan prefecture and Yunnan province dispersed among all CRF07_BC
strains in the phylogenetic tree; these are different from Xinjiang strains.
Xinjiang CRF07_BC sequences were grouped into several clusters with a
large genetic distance from other sequences and high bootstrap values. This
suggests that multiple introductions of CRF07_BC strains into Xinjiang
province occurred. The MCMC analysis further proved the results and
demonstrated that most of the introductions happened at the end of the
15

1990s. Our data refuted the contention that CRF07_BC was first introduced
into Xinjiang province and supported the contention that it was introduced
into Yunnan and Sichuan provinces before being introduced into Xinjiang
province. More sequences from Gansu, Ningxi, and Shanxi provinces, which
are between Sichuan and Xinjiang provinces, will be helpful in absolutely
demonstrating the temporal and geographic migration of CRF07_BC in
China.
Highly active antiretroviral therapy (HAART) has been widely employed in
China since the start of the “Four Free and One Care” policy in 2003. With
the widespread use of HAART, HIV-1 drug resistance has become an issue
in some areas of China. For example, in 2005, a high ratio of HIV drugresistant mutations (20.8%) was reported in patients (n=124) treated with
ART in Henan province, central China.49 In the IDU population, the data
from the Chinese National (HIVDR) Surveillance and Monitoring Network
showed that 20.8% of individuals undertaking first line drugs experienced
virological failure.50 Here we found that a low level of drug-resistant strains
was found in Liangshan, suggesting that the ART program in Liangshan is
functioning well.
According to the WHO HIVDR Threshold Surveillance protocol, our study
population was below the threshold of 5%, suggesting that there are wellfunctioning ART programs in Liangshan prefecture and the transmission of
RTI and protease mutant viruses is still minimal. However, with the recent
scale up of free HAART in Liangshan and the spread of HIV among
different high-risk populations, drug resistance surveillance will still be
needed in the region.
In summary, we have carried out a comprehensive survey and genetic
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characterization of the HIV strains that are prevalent in the IDU population
in Liangshan prefecture, which we believe is the most complete analysis to
date. We found that CRF07_BC is still highly dominant in the IDU
population, even 20 years after its initial identification in the first outbreak
in China. High genetic diversity was found when compared to strains
prevalent in other areas. A close relationship was identified between these
strains and those from Yunnan province, and relatively low levels of drugresistant mutations were found. Phylogenetic analysis showed that
CRF07_BC strains should be introduced into Xinjiang province following
drug traffic from Yunnan province, through Liangshan prefecture of
Sichuan, Gansu, and Qinghai provinces. The detailed CRF07_BC sequence
information will provide basic information for designing intervention
strategies and for HIV vaccine design.

Sequence Data
The gene sequences were deposited in GenBank with the following
accession number: KJ820145–KJ820408, KP234525-KP234916, and
KP234917-KP235200.
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FIG. 1.
Geographic location of Liangshan prefecture in China and area information of
reference sequences. Map of China highlighting Liangshan prefecture, Sichuan
province. Provinces containing reference sequences for CRF07_BC phylogenetic
analysis are labeled in color according to that used in the maximum likelihood (ML)
tree and maximum clade credibility (MCC) tree. Color images available online at
www.liebertpub.com/aid
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TABLE 1.
BACKGROUND CHARACTERISTICS OF PARTICIPANTS

Total N=502
Characteristics

N (%)

Age (years)
2–14

3 (0.6)

15–29

226 (45.0)

30–44

254 (50.6)

45–59

17 (3.4)

≥60

2 (0.4)

Gender
Male

394 (78.5)

Female

108 (21.5)

Ethnic
Han ethnic

21 (4.2)

Bai minority ethnic

59 (11.8)

Yi minority ethnic

420 (83.7)

24

Unknown

2 (0.4)

Route of transmission
Heterosexual
IDU

4 (0.8)
489 (97.4)

Mother to children

1 (0.2)

Unknown

8 (1.6)

CD4+ count (cells/μl)
≤200

44 (8.8)

201–350

112 (22.3)

351–500

158 (31.5)

≥501

188 (37.5)

IDU, intravenous drug use.
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FIG. 2.
Phylogenetic tree analysis. Neighbor-joining trees were created with the full length
gag (a) and pol (b) genes of HIV-1 sequences from the intravenous drug use (IDU)
population in Liangshan prefecture and a selection of reference sequences of
subtype A–D, F–H, J, K, CRF01_AE, CRF07_BC, and CRF08_BC (black dots,
http://hiv-web.lanl. gov/). The lengths of the gag and pol genes of HIV-1 sequences
obtained in the study were 1,503 and 3,056 base pairs using HXB2 as the genomic
calibrator. Each reference sequence is labeled with the HIV-1 subtype, followed by
the sequence name. The bootstrap values supporting the branch (more than 70%)
are indicated at the corresponding nodes of the tree. The scale bars representing
genetic distances are listed below.
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FIG. 3.
Evolutionary relationship between Liangshan HIV-1 CRF07_BC sequences from the
IDU population and those from other areas in China depicted on a maximum
likelihood tree of the full-length gag–pol gene (A) and partial gag gene (B). (A) Fulllength gag–pol sequences representing CRF07_BC from several areas were
identified in the laboratory or obtained from the database (http://hiv-web.lanl. gov/)
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and used for comparison with the sequences generated in this study. Each reference
sequence is labeled using the same color used in Fig. 1. The branch support values
(more than 70%) are indicated at the corresponding nodes of the tree. The subtree
containing clusters is illustrated at the right of the original tree. (B) The ML tree based
on partial CRF07_BC gag sequences representing CRF07_BC from several areas
is constructed to illustrate the evolutionary relationship between strains from
Liangshan prefecture and Xinjiang province. The subtree containing clusters is
illustrated accordingly. Color images available online at www.liebertpub.com/aid
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FIG. 4.
Maximum clade credibility trees of the HIV-1 CRF07_BC sequences from China
based on the partial gag gene. All of the sequences are labeled using the same
colors used in Fig. 1. The dates of MRCA and posterior probability are labeled
beside each node. Color images available online at www.liebertpub.com/aid
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TABLE 2.
PRIMARY DRUG-RESISTANT MUTATIONS ASSOCIATED WITH PROTEASE AND REVERSE TRANSCRIPTASE GENES
AMONG TREATMENT NAÏVE PARTICIPANTS

Targeting drugs of
resistant mutations
Sample

Subtype

PI

916

CRF07_BC M46L

964

CRF07_BC

1128

CRF07_BC

1141

CRF07_BC

1415

CRF07_BC

NRTI

NNRTI

Resistant profile
Low Intermediate High
NFV
AZT,
d4T

T215I

EFV,
NVP

K103N
AZT,
d4T

D67N
G190A

EFV

NVP

PI, protease inhibitors; NRTI, nucleoside reverse transcriptase inhibitors; NNRTI, nonnucleoside
reverse transcriptase inhibitors; AZT, zidovudine; d4T, stavudine; EFV, efavirenz; NFV, nelfinavir;
NVP, nevirapine.
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